Betibeglogene autotemcel

Generic name: Betibeglogene Autotemcel
Brand names: Zynteglo
Dosage form: intravenous suspension (-)
Drug class: Miscellaneous uncategorized agents

Usage of Betibeglogene autotemcel

Betibeglogene autotemcel is used to treat beta-thalassemia (Cooley's Anemia) in people at least 4 years old who need blood transfusions often.

Betibeglogene autotemcel may also be used for purposes not listed in this medication guide.

Betibeglogene autotemcel side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Betibeglogene autotemcel may cause serious side effects. Call your doctor at once if you have:

fast heart rate;

severe headache;

nosebleeds;

blood in your stool or urine;

unusual stomach or back pain;

if you are vomiting or coughing up blood;

easy bruising, unusual bleeding, purple or red spots under your skin; or

low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough.

Common side effects of betibeglogene autotemcel may include:

fast heart rate;

stomach pain;

pain in your arms or legs;

easy bruising, unusual bleeding, purple or red spots under your skin; or

low white blood cell counts.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Betibeglogene autotemcel

Ask a doctor or pharmacist before using betibeglogene autotemcel if you have health problems or use other medications.

Do not use if you are pregnant. Use effective birth control while using betibeglogene autotemcel and for at least 6 months after your last dose. Tell your doctor if you become pregnant.

Do not breastfeed.

Betibeglogene autotemcel may affect fertility in men or women. Ask your doctor about saving semen and eggs before treatment.

Relate drugs

How to use Betibeglogene autotemcel

Follow all directions on your prescription label and read all medication guides or instruction sheets.

Betibeglogene autotemcel is injected into a vein by a healthcare provider. You will be given other medicines as part of your treatment with betibeglogene autotemcel.

After betibeglogene autotemcel injection, you will stay in the hospital for approximately 3 to 6 weeks to monitor your recovery. Your doctor will determine when you can go home.

This medicine may cause false results on a HIV (human immunodeficiency virus) test. Tell the laboratory staff that you use betibeglogene autotemcel.

Your blood will need to be tested often.

Warnings

Call your doctor at once if you have severe headache, abnormal bruising, nosebleeds, blood in your urine or stool, stomach pain, back pain, or if you cough up blood or vomit.

What other drugs will affect Betibeglogene autotemcel

Tell your doctor about all your other medicines, especially:

iron chelators such as deferoxamine, deferasirox, or deferiprone;

HIV/AIDS medications; or

hydroxyurea.

This list is not complete. Other drugs may affect betibeglogene autotemcel, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.